Copyright
©The Author(s) 2017.
World J Cardiol. Jul 26, 2017; 9(7): 562-573
Published online Jul 26, 2017. doi: 10.4330/wjc.v9.i7.562
Published online Jul 26, 2017. doi: 10.4330/wjc.v9.i7.562
Figure 1 Proposed Mechanisms by which biologics and disease modifying anti-rheumatic drugs will reduce the risk of sudden cardiac death in patients with rheumatoid arthritis.
DMARD: Disease modifying anti-rheumatic drugs; HTN: Hypertension; DM: Diabetes; TNF: Tumour necrosis factor; IL: Interleukin; HRV: Heart rate variability; QTc: Corrected QT interval; QTd: QT interval dispersion.
- Citation: Masoud S, Lim PB, Kitas GD, Panoulas V. Sudden cardiac death in patients with rheumatoid arthritis. World J Cardiol 2017; 9(7): 562-573
- URL: https://www.wjgnet.com/1949-8462/full/v9/i7/562.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i7.562